- Home
- DSGN vs GWRS Comparison
DSGN vs GWRS Comparison
Compare DSGN & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- GWRS
- Stock Information
- Founded
- DSGN 2017
- GWRS 2003
- Country
- DSGN United States
- GWRS United States
- Employees
- DSGN N/A
- GWRS N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- GWRS Water Supply
- Sector
- DSGN Health Care
- GWRS Utilities
- Exchange
- DSGN Nasdaq
- GWRS Nasdaq
- Market Cap
- DSGN 353.9M
- GWRS 321.8M
- IPO Year
- DSGN 2021
- GWRS 2010
- Fundamental
- Price
- DSGN $6.25
- GWRS $11.69
- Analyst Decision
- DSGN Hold
- GWRS
- Analyst Count
- DSGN 3
- GWRS 0
- Target Price
- DSGN $7.00
- GWRS N/A
- AVG Volume (30 Days)
- DSGN 208.4K
- GWRS 35.7K
- Earning Date
- DSGN 11-07-2024
- GWRS 11-06-2024
- Dividend Yield
- DSGN N/A
- GWRS 2.57%
- EPS Growth
- DSGN N/A
- GWRS N/A
- EPS
- DSGN N/A
- GWRS 0.27
- Revenue
- DSGN N/A
- GWRS $51,809,000.00
- Revenue This Year
- DSGN N/A
- GWRS $0.79
- Revenue Next Year
- DSGN N/A
- GWRS $4.58
- P/E Ratio
- DSGN N/A
- GWRS $43.52
- Revenue Growth
- DSGN N/A
- GWRS 0.10
- 52 Week Low
- DSGN $2.25
- GWRS $11.41
- 52 Week High
- DSGN $7.77
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- DSGN 52.38
- GWRS 31.49
- Support Level
- DSGN $5.55
- GWRS $12.30
- Resistance Level
- DSGN $6.45
- GWRS $12.57
- Average True Range (ATR)
- DSGN 0.56
- GWRS 0.33
- MACD
- DSGN -0.04
- GWRS -0.12
- Stochastic Oscillator
- DSGN 57.67
- GWRS 5.52
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operate within the State of Arizona.